Back
Blackstone, Inc. 10K Form
Buy
60
BX
Blackstone, Inc.
Last Price:
$151.39
Seasonality Move:
5.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-03 | 10Q | BX/Blackstone, Inc. Quarterly |
| 2023-08-04 | 10Q | BX/Blackstone, Inc. Quarterly |
| 2023-05-05 | 10Q | BX/Blackstone, Inc. Quarterly |
| 2022-11-04 | 10Q | BX/Blackstone, Inc. Quarterly |
| 2022-08-05 | 10Q | BX/Blackstone, Inc. Quarterly |
| 2022-05-05 | 10Q | BX/Blackstone, Inc. Quarterly |
Receive BX News And Ratings
See the #1 stock for the next 7 days that we like better than BX
BX Financial Statistics
Sales & Book Value
| Annual Sales: | $12.5B |
|---|---|
| Cash Flow: | $865.6M |
| Price / Cash Flow: | 57.24 |
| Annual Sales: | $6.83 |
| Price / Book: | 13.95 |
Profitability
| EPS (TTM): | 3.48680 |
|---|---|
| Net Income (TTM): | $5.4B |
| Gross Margin: | $12.3B |
| Return on Equity: | 26.67% |
| Return on Assets: | 12.1% |
Blackstone, Inc. Earnings Forecast
Key Blackstone, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for BX is 98.76%.
-
The Selling, General & Administrative Expenses for BX have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 8.16% of Operating Income.
-
The Net Earning history of BX is 43.65% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 15 years.
Blackstone, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Capital Markets |
| Sector: | Financials |
| Current Symbol: | BX |
| CUSIP: | 09253U |
| Website: | blackstone.com |
Debt
| Debt-to-Equity Ratio: | 1.54 |
|---|---|
| Current Ratio: | 0.75 |
| Quick Ratio: | 0.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 41.8 |
|---|---|
| Forward P/E Ratio: | 23.54 |
BX Technical Analysis vs Fundamental Analysis
Buy
60
Blackstone, Inc. (BX)
is a Buy
Is Blackstone, Inc. a Buy or a Sell?
-
Blackstone, Inc. stock is rated a BuyThe current Blackstone, Inc. [BX] share price is $151.39. The Score for BX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.